New findings to the role of tunikamycin in grapevine: Disease defense responses
DOI:
https://doi.org/10.5073/vitis.2001.40.169-174Keywords:
Vitis vinifera L., Limberger, elicitor, defense, apoptosis, N-linked glycosylationAbstract
Exogenous methyl jasmonate (MeJA) is an effective trigger of cellular damage resulting in the development of limited necrotic lesions that mimic the hypersensitive reaction (HR) lesions associated with resistance to avirulent pathogens. Localized treatment of leaves of intact grapevines (Vitis vinifera L. cv. Limberger) or excised leaves with tunikamycin stimulates an agonist-dependent mechanism operating at an early step in the signal pathway for induction of MeJA-dependent UR-like response. With respect to tunikamycin, the fine control mechanism has shown to be both, concentration- and time-dependent. The same treatment also antagonized H2O2 accumulation from the MeJA-induced oxidative burst suggesting that this type of reactive oxygen intermediate plays a minor role in the induction of the HR in grapevine cells challenged by exogenous MeJA. Moreover, our results indicate that the activation of defense reactions of grapevine, at least in part, is dependent and sensitive to N-linked glycosylation.
Downloads
Published
Issue
Section
License
The content of VITIS is published under a Creative Commons Attribution 4.0 license. Any user is free to share and adapt (remix, transform, build upon) the content as long as the original publication is attributed (authors, title, year, journal, issue, pages) and any changes to the original are clearly labeled. We do not prohibit or charge a fee for reuse of published content. The use of general descriptive names, trade names, trademarks, and so forth in any publication herein, even if not specifically indicated, does not imply that these names are not protected by the relevant laws and regulations. The submitting author agrees to these terms on behalf of all co-authors when submitting a manuscript. Please be aware that this license cannot be revoked. All authors retain the copyright on their work and are able to enter into separate, additional contractual arrangements.